The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
COMy Virtual 2020 | MGUS progression to overt myeloma: the tumor microenvironment
Irene Ghobrial, MD, Dana-Farber Cancer Institute, Boston, MA, discusses the role of the microenvironment in multiple myeloma precureser conditions from MGUS, to smoldering myeloma to averse myeloma. Specifically, the changes from each disease are explored, including immune changes, such as cellular composition, signalling pathways and gene expression profile. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
